drugset / Trial / NCT00236730

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

NCT00236730

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effectiveness and safety of topiramate as add-on therapy in patients with difficult to control partial onset seizures who are taking one or two standard anti-epileptic drugs.

Timeline

Start
1988-06
Primary completion
Completion
1990-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 200 mg Oral
Subject Topiramate Small molecule 400 mg Oral
Subject Topiramate Small molecule 600 mg Oral

Indications